Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 525-527

  Retzlaff, Stefan ^a   Padró, Teresa ^a   Koch, Peter ^a   Oelmann, Elisabeth ^a   Lügering, Norbert ^a   Mesters, Rolf M ^a   Berdel, Wolfgang E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Flt3 ligand; Interleukin 8; Non Hodgkin's lymphoma

Indexed keywords

CYTOKINE; FLT3 LIGAND PROTEIN; INTERLEUKIN 8; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA; PROGNOSIS; TIME;

ADULT; AGED; CYTOKINES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INTERLEUKIN-8; LYMPHOMA, NON-HODGKIN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; TIME; TUMOR MARKERS, BIOLOGICAL;

EID: 0036584679     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.525     Document Type: Article

References (12)

1. Poon RT-P, Sheung T-F and Wong J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19:1207-1225,2001. (Pubitemid 32176299)
2. Salven P, Teerenhovi L and Joensuu H: A high serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90: 3167-3172, 1997. (Pubitemid 27444212)
3. Salven P, Teerenhovi L and Joensuu H: A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. Blood 94: 3334-3339, 1999. (Pubitemid 29536126)
4. Molica S, Vitelli G, Levato D, Gandolfo GM and Liso V: Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 107: 605-610, 1999.
5. Salven P, Orpana A, Teerenhovi L and Joensuu H: Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 96: 3712-3718, 2000.
6. Zucca E, Bertoni F, Roggero E and Cavalli F: The gastric marginal zone B-cell lymphoma of MALT type. Blood 96: 410-419, 2000. (Pubitemid 30463357)
7. Koch P, Del Valle F, Berdel WE, et at Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol 19: 3861-3873, 2001.
8. Koch P, Del Valle F, Berdel WE, et al: Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma. Results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol 19: 3874-3883, 2001. (Pubitemid 32880066)
9. Moore BB, Arenberg DA, Addison CL, Keane MP and Strieter RM: Tumor angiogenesis is regulated by CXC chemokines. J Lab Clin Med 132: 97-103, 1998. (Pubitemid 28378838)
10. Konturek PC, Konturek SJ, Starzyska T, et al: Helicobacter py/on'-gastrin link in MALT lymphoma. Aliment Pharmacol Therl4: 1311-1318,2000.
11. Lyman SD and Jacobsen SEW: C-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood91: 1101-1134, 1998. (Pubitemid 28086863)
12. Solanilla A, Grosset C, Lemercier C, et al: Expression of FIt3-ligand by the endothelial cell. Leukemia 14: 153-162. 2000.